PHGDH and RBKS were also identified as candidate predictive biomarkers via differential abundance analysis, which suggested that these proteins are likely predictive biomarkers to evaluate the occurrence of AMS in individuals before their ascension to high altitude. The gene discussed is RBKS; the disease is ablepharon macrostomia syndrome.